daidzin has been researched along with Bone Loss, Osteoclastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, T; Lu, Q; Nong, X; Wei, C; Wei, G; Zhao, J | 1 |
1 other study(ies) available for daidzin and Bone Loss, Osteoclastic
Article | Year |
---|---|
Daidzin inhibits RANKL-induced osteoclastogenesis in vitro and prevents LPS-induced bone loss in vivo.
Topics: Animals; Bone Resorption; Cathepsin K; Cell Differentiation; Disease Models, Animal; Humans; Isoflavones; Lipopolysaccharides; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; RANK Ligand; Receptors, Thrombin; Signal Transduction | 2019 |